Glioma-astrocyte interaction modifies the astrocyte phenotype in a co-culture experimental model

Department of Human Morphology and Biomedical Sciences Città Studi, Extracellular Matrix Laboratory-EML, School of Medicine, University of Milan, Milano, Italy.
Oncology Reports (Impact Factor: 2.3). 12/2009; 22(6):1349-56. DOI: 10.3892/or_00000574
Source: PubMed


As the majority of gliomas arise through malignant transformation of astrocytes, we aimed at investigating the interaction between malignant glioma cells and astrocytes in a co-culture experimental model. For this purpose we analyzed the expression of genes and proteins involved in tumor promotion and invasion, such as glial fibrillary acidic protein (GFAP), matrix metalloproteinase-2 (MMP-2), tissue inhibitor of MMP-2 (TIMP-2), transforming growth factor-beta1 (TGF-beta1), secreted protein acidic and rich in cysteine (SPARC), and connexin 43 (CX43). Co-cultures of human neural stem cell-derived astrocytes and U87 MG astrocytoma cells were performed in a transwell system. Gene expression was evaluated by real-time RT-PCR, and protein analysis was performed by Western blotting, SDS-zymography, and immunofluorescence. GFAP tended to be up-regulated in astrocytes co-cultivated with U87, suggesting a reactive response induced by glioma cells. CX43 mRNA tended to be down- regulated in co-cultured astrocytes, as well as the non-phosphorylated isoform at the protein level. MMP-2 mRNA tended to be up-regulated, and MMP-2 protein levels were significantly increased in astrocytes co-cultivated with U87. TIMP-2 and SPARC mRNA decreased in astrocytes co-cultivated with U87, showing lower expression in glioma cells. By contrast, SPARC protein expression was strongly induced in supernatants of co-cultured astrocytes. TGF-beta1 was not modified. Our results suggest that U87 cells elicit phenotype modifications in the neighbouring resident astrocytes very likely mediated by soluble factors. Glioma/astrocyte interaction could possibly trigger an astrocyte phenotype modification consistent with a malignant transformation, and favouring a more permissive environment for glioma cells invasion.

Download full-text


Available from: Nicoletta Gagliano, Oct 06, 2015
1 Follower
35 Reads
  • Source
    • "Some aggressive tumors including glioblasomas were shown to release microvesicles (exosomes) containing mRNA, DNA, enzymes, oncogenic receptors, growth factors, and miRNA, which after their uptake by surrounding non-tumors cells induce oncogenic transformation of neighbors (Al-Nedawi et al., 2008; Antonyak et al., 2011; Graner et al., 2009; Skog et al., 2008). Co-cultivating of human neural stem cell-derived astrocytes and U87 MG astrocytoma cells resulted in the malignantlike phenotype acquired by astrocytes from tumor cells (Gagliano et al., 2009). Recently, Katakowski et al. (2010) observed the ability of culturing rat gliosarcoma and human glioma cell lines share miRNA between neighboring cells through gap junctions, and this miRNA has a functional effect in the recipient cell via inhibiting expression of a target mRNA. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glioblastomas, particularly high grade brain tumors such as glioblastoma multiforme, are characterized by increased anaplasy, malignancy, proliferation, and invasion. These tumors exhibit high resistance to radiation therapy and treatment with anti-cancer drugs. The radio- and chemoresistance of gliomas is attributed to cancer stem cells (CSCs) that are considered as major contributors for maintenance and propagation of tumor cell mass, cancer malignancy and invasiveness, and tumor cell survival after courses of radiotherapy and medical interventions. MicroRNAs (miRNAs), key post-transcriptional gene regulators, have altered expression profiles in gliomas. Some of miRNAs whose expression is markedly up-regulated in brain tumors are likely to have a pro-oncogenic role through supporting growth, proliferation, migration, and survival of cancer stem and non-stem cells. In contrast, a population of miRNA possessing anti-tumor effects is suppressed in gliomas. In this review, we will consider miRNAs and their influence on radio- and chemoresistance of gliomas. These miRNAs harbor a great therapeutic significance as potent agents in future targeted anti-cancer therapy to sensitize glioma tumor cells and CSCs to cytotoxic effects of radiation exposure and treatment with anti-cancer drugs.
    European journal of pharmacology 03/2012; 684(1-3):8-18. DOI:10.1016/j.ejphar.2012.03.031 · 2.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Medulloblastomas (MBs) are the most common malignant brain tumor in children. The current therapeutic strategies are ineffective against the infiltrative and disseminative nature of MBs in about one-third of patients. Based on studies which have revealed the tumor-tropic characteristic of neural stem cells (NSCs), we used an immortalized neural stem cell line C17.2 as a cellular therapeutic delivery system to evaluate the antitumor effect of herpes simplex virus thymidine kinase gene (HSVtk) on MBs. We first stably transfected the HSVtk gene into C17.2 cells to produce C17.2tk cells, and then mixed C17.2tk with the human MB cell line Daoy at various ratios supplemented with ganciclovir (GCV). Both in vitro and in vivo experiments yielded promising results. Even at a C17.2tk: Daoy ratio as low as 1:16, more than 25% cells were killed in vitro. In vivo co-implantation study showed that when C17.2tk: Daoy ratio was 1:8, tumor growth inhibition was still evident and the mice had significantly prolonged survival. These results might partially be explained by the inherent tumor-tropic properties of NSCs and the bystander effect coupled with expression of connexin-43 (Cx43) between C17.2tk and Daoy cells. Our study clearly showed for the first time that immortalized neural stem cells used as vectors to deliver HSVtk gene therapy have a strong tumoricidal effect on MBs.
    Brain research 11/2010; 1369:245-52. DOI:10.1016/j.brainres.2010.10.107 · 2.84 Impact Factor
Show more